Philips provides update on completed set of test results for CPAP/BiPAP sleep therapy devices
May 16, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), today provides an update on the comprehensive test and research program of its subsidiary Philips Respironics to assess potential health risks related to the polyester-based polyurethane (PE-PUR)